CCCC vs MMC · rev $35.6M vs P/E 22, rev $24.46B
C4 Therapeutics Inc (CCCC) versus Marsh & McLennan Companies Inc (MMC) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
CCCC currently screens at market cap $425.7M. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Not investment advice. Open the CCCC and MMC stock pages for the full models.
Not investment advice.